Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy

BACKGROUND: Respiratory syncytial virus (RSV) infections in lung transplant recipients (LTRs) have been associated with significant morbidity and mortality. Immunoglobulins, ribavirin, and palivizumab are suggested treatments for both pre-emptive and therapeutic purposes. However, in the absence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Uçkay, Ilker, Gasche-Soccal, Paola M., Kaiser, Laurent, Stern, Richard, Mazza-Stalder, Jesica, Aubert, John-David, van Delden, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Heart and Lung Transplantation. Published by Elsevier Inc. 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173010/
https://www.ncbi.nlm.nih.gov/pubmed/19837611
http://dx.doi.org/10.1016/j.healun.2009.08.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173010/
https://www.ncbi.nlm.nih.gov/pubmed/19837611
http://dx.doi.org/10.1016/j.healun.2009.08.012

Ejemplares similares